Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSC-MSC-Exo Eye Drops for Dry Eye Disease
NCT05738629Phase 2Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Mar 2023
- Primary completion
- Feb 2025
- Modality
- Lipid-based Nanoparticles, Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 2 trial of pluripotent stem cell-derived mesenchymal stem cell exosome in dry eye disease (DED), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Drugs
pluripotent stem cell-derived mesenchymal stem cell exosome
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05738629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05738629.